CK
Colleen Kusy Baird Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Apellis Pharmaceuticals
APLS
$3.55B
| $28.13 | $50 |
78%
upside
| Outperform | 1 month ago |
|
2
Nuvalent
NUVL
$5.83B
| $80.89 | $112 |
38%
upside
| Outperform | 2 months ago |
|
3
Enliven Therapeutics
ELVN
$1.19B
| $20.15 | $52 |
158%
upside
| Outperform | 2 months ago |
|
4
Oculis Holding
OCS
$901M
| $17.22 | $41 |
138%
upside
| Outperform | 5 months ago |
|
5
Spyre Therapeutics
SYRE
$1.03B
| $17 | $65 |
282%
upside
| Outperform | 9 months ago |
|
6
Ocular Therapeutix
OCUL
$2.37B
| $13.60 | $17 |
25%
upside
| Outperform | 1 year ago |
|
7
Oric Pharmaceuticals
ORIC
$1.06B
| $10.88 | $25 |
130%
upside
| Outperform | 1 year ago |
|
8
Iovance Biotherapeutics
IOVA
$901M
| $2.49 | $34 |
1,265%
upside
| Outperform | 3 years ago |
|